CIK 0001782223
- Emerging growth company
Pyxis Oncology, Inc.
Sign in to watch- Ticker
- PYXS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831160910
- Phone
- +1 617-221-9059
- Business address
- 321 HARRISON AVENUE, BOSTON, MA, 02118
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-K/A Report 10-K/A
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations · Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Unregistered share sale
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 8-K Event Executive or director change
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Other events
- 10-K Report Annual Report
- 8-K Event Results of operations · Other events
Page 4 of 5 · 82 filings